Got an Xbox Game Pass Premium subscription? Then today is your lucky day, because four new games just landed in the library.
Here's the slightly confusing part: these titles aren't brand new to Game Pass overall. They've actually been sitting in the Ultimate and PC Game Pass libraries already, and now they're hopping over to the mid tier. So if you're a Premium subber, they're fresh to you. If you're on Ultimate, you've probably already had a crack at them.
The headliner here is Marvel Cosmic Invasion, a retro-inspired beat 'em up that scored very well right out of the gate. If you grew up mashing buttons on classic side-scrolling brawlers, this one sounds like it was built with you in mind. Strong early reviews plus a Marvel logo? That's a pretty tempting combo.
Then there's Routine, a sci-fi horror set in space. Our writer hadn't actually played it yet at the time of writing, but was clearly sold on the vibe alone, calling it scary and noting that it looks seriously cool. Space plus horror is a combination that rarely misses, so this could be the sleeper pick of the bunch.
The source article only names those two titles directly, so we won't pretend to know the other two additions. If you want the full list, the original piece over on purexbox.com has the complete rundown.
What this really shows is how the Game Pass tiers are shaping up. Premium sits in the middle, and days like this are exactly what make it appealing: games that already proved themselves on the higher tiers trickling down to your subscription. You're not getting day-one blockbusters, but you are getting a steady stream of titles with a bit of a track record.
So if you've got Premium and you're staring at your backlog wondering what to play tonight, you've got four new options as of today. Marvel Cosmic Invasion looks like the safest bet if you want action, while Routine should scratch that creepy space itch.
What do you think? Will you be jumping into Marvel Cosmic Invasion, braving Routine, or skipping all four? Let us know in the comments.
Comments (0)
Log in to join the discussion
Log InNo comments yet